Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV- infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 567-575

  Stiehm, E Richard ^a,b,c,d,e,f   Lambert, John S ^a,b,c,d,e,f   Mofenson, Lynne M ^a,b,c,d,e,f   Bethel, James ^a,b,c,d,e,f   Whitehouse, Jean ^a,b,c,d,e,f   Nugent, Robert ^a,b,c,d,e,f   John Jr , Moye ^a,b,c,d,e,f   Fowler, Mary Glenn ^a,b,c,d,e,f   Mathieson, Bonnie J ^{a,b,c,d,e,f,g}   Reichelderfer, Patricia ^{a,b,c,d,e,f,g}   Nemo, George J ^a,b,c,d,e,f   Korelitz, James ^a,b,c,d,e,f   Meyer III, William A ^a,b,c,d,e,f   Sapan, Christine V ^a,b,c,d,e,f   Jimenez, Eleanor ^a,b,c,d,e,f   Gandia, Jorge ^a,b,c,d,e,f   Scott, Gwendolyn ^a,b,c,d,e,f   O'Sullivan, Mary Jo ^a,b,c,d,e,f   Kovacs, Andrea ^a,b,c,d,e,f   Stek, Alice ^a,b,c,d,e,f   Shearer, William T ^a,b,c,d,e,f   Hammill, Hunter ^a,b,c,d,e,f   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Division of AIDS ^*  (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e San Juan City Hospital   (Puerto Rico)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYPERIMMUNE GLOBULIN; LAMIVUDINE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BACKACHE; BLOOD TOXICITY; CHILL; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; BIRTH WEIGHT; CESAREAN SECTION; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; GESTATIONAL AGE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PUERTO RICO; UNITED STATES; ZIDOVUDINE;

EID: 18544391179     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314637     Document Type: Article

References (35)

1. 1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. 2. Report of a Consensus Workshop, Siena, Italy, January 17 18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 1992;5:1019-29.
3. 3. European Collaborative Study, Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
4. 4. Jackson JB, Kataaha P, Horn DL, et al. β-2 microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993;7:1475-9.
5. 5. Rouzioux C, Costagliola D, Burgard M, et al. Timing of mother-to-child HIV-1 transmission depends on maternal status. AIDS 1993;7(suppl 2): S49-52.
6. 6. Thomas PA, Weedon J, Krasinski K, et al. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994; 13:489-95.
7. 7. Mayaux MJ, Teglas JP, Mandelbrot L, et al. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr 1997;131:857-62.
8. 8. Van Rompay KKA, Berardi CJ, Dillard-Telm S, et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998;177:1247-59.
9. 9. Gauduin MC, Parren PQHI, Weir R, Barbas CF, Burton DR, Koup RA. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mite against challenge by primary isolates of HIV-1. Nat Med 1997;3:1389-93.
10. 10. Pu R, Okada S, Littile ER, Xu B, Stoffs WV, Yamamoto JK. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies. AIDS 1995;9:235-42.
11. 11. Putkonen P, Thorxtensson R, Ghavamzadeh L, et al. Prevention of HIV-2 and SIV infection by passive immunization in cynomolgus monkeys. Nature 1991;352:436-8.
12. 12. Emini EA, Schleif WA, Nunberg JH, et al. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 1992;355:728-30.
13. agm infection in African green monkey natural host. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:217-26.
14. 14. Gardner MB, Rosenthal A, Jennings M, Yee JA, Antipa L, MacKenzie M. Passive immunization of macaques against SIV infection. J Med Primatol 1994;23:164-74.
15. mac251. AIDS Res Hum Retroviruses 1994;10:189-94.
16. 16. Lambert JS, Mofenson LM, Fletcher CV, et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J Infect Dis 1997;175:283-91.
17. 17. Cummins LM, Weinholt KJ, Matthew TJ, et al. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Blood 1991;77:1111-7.
18. 18. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
19. 19. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14: 702-15.
20. 20. Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Controlled Clin Trials 1984;5:348-61.
21. 21. Gelber RV, Lindsey JC, MaWhinney S. Clinical trials to reduce the risk of maternal-infant transmission of HIV infection. In: Finkelstein DM, Shoenfeld DA, eds. AIDS clinical trials. New York: John Wiley & Sons, 1995.
22. 22. Marubini E, Valsechhi MG. Analyzing survival data from clinical trials and observational studies. In: Finkelstein DM, Shoenfeld DA, eds. AIDS clinical trials. New York: John Wiley & Sons, 1995.
23. 23. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:145-52.
24. 24. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observation. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8: 188-94.
25. 25. Newell ML, Dunn DT, Peckham CS, Semprini AE, Pardi G. Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996;10:1675-81.
26. 26. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 1998;12:301-8.
27. 27. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992;15:678-91.
28. 28. Ebbesen P, Toth F, Aboagye-Mathiesen G, et al. Vertical transmission of HIV: possible mechanisms and placental responses. Trophoblast Res 1994;8:1-17.
29. 29. Schwartz DA, Nahmias AJ. Human immunodeficiency virus and the placenta: current concepts of vertical transmission in relation to other viral agents. Ann Clin Lab Sci 1991;21:264-74.
30. 30. Reuben J, Lee BN, Popek EJ. HIV and the placenta. Immunol Allergy Clin North Am 1998;18:371-400.
31. 31. Purswani MU, Johann-Liang R, McNeeley M, Noel GJ. Effect of intravenous immune globulin (IVIG) on interleukin-6 (IL-6) production by whole blood [abstract 894]. Pediatr Res 1998;43(part 2):154A.
32. 32. Mofenson LM. Mother-child HIV-1 transmission: timing and determinants. Obstet Gynecol Clin North Am 1997;24:759-84.
33. 33. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Importance of maternal ZDV therapy in the reduction of perinatal transmission of HIV [abstract 379]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
34. 34. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-14.
35. 35. Haigwood NL, Watson A, Sutton WF, et al. Passive immune globulin therapy in SIV/macaque model: early intervention can alter disease profile. Immunol Lett 1996;51:107-14.